Carregant...
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes
The prevalence of type 2 diabetes mellitus (T2DM) is rising in Australia. Sodium glucose co-transporter 2 (SGLT2) inhibitors are an emerging treatment for T2DM. SGLT2 inhibitors offer a novel approach to lowering hyperglycaemia by suppressing renal glucose reabsorption and increasing urinary glucose...
Guardat en:
| Publicat a: | Australas Med J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Australasian Medical Journal
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221776/ https://ncbi.nlm.nih.gov/pubmed/25379062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4066/AMJ.2014.2181 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|